Evidence map›Paper›PMID 42578411›Full record

ArticleMolecular oncology2026

Spatial and single-nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers.

Adrien Tourneur, Joel Rodrigues Vitória, Manuel Saiselet, Ligia Craciun, Denis Larsimont, Anne Lefort, Frédérick Libert, Carine Maenhaut, Sabine Costagliola, Maxime Tarabichi and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Adrien TourneurIRIBHM Jacques E. Dumont, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Joel Rodrigues VitóriaIRIBHM Jacques E. Dumont, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Manuel SaiseletIRIBHM Jacques E. Dumont, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Ligia CraciunDepartment of Pathology, Institut Jules Bordet, Bruxelles, Belgium.
Denis LarsimontDepartment of Pathology, Institut Jules Bordet, Bruxelles, Belgium.
Anne LefortIRIBHM Jacques E. Dumont, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Frédérick LibertIRIBHM Jacques E. Dumont, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Carine MaenhautIRIBHM Jacques E. Dumont, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Sabine CostagliolaIRIBHM Jacques E. Dumont, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Maxime TarabichiIRIBHM Jacques E. Dumont, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Mirian RomittiIRIBHM Jacques E. Dumont, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Vincent DetoursIRIBHM Jacques E. Dumont, Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID https://orcid.org/0000-0002-8215-3662

Funding

Fondation Héger-MassonFondation Jaumotte-DemoulinFonds Alice et David van BuurenFonds De La Recherche Scientifique - FNRS J.0068.22Fonds National de la Recherche Luxembourg 11587122Fonds pour la Formation à la Recherche dans l'Industrie et dans l'Agriculture 1.E.019.21FStichting Tegen Kanker FCC 2020-072Universite Libre de Bruxelles Advanced ARC
6 · The paper itself

Abstract

Sixty percent of papillary thyroid cancers (PTCs) are driven by BRAF

Indexed as

anaplastic thyroid cancerdedifferentiationpapillary thyroid cancersingle‐nuclei RNA sequencingspatial transcriptomicstranscriptional patterns

Identifiers

PMID42578411
PMCPMC13459077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.